Sunrise Clinics Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Not Enrolled in Medicare Practice Location: 658 S 5th St, Santa Rosa, NM 88435 Phone: 575-472-7747 Fax: 877-651-0289 |
Sunrise Medical Group, Pc Clinic/Center - Primary Care Medicare: Medicare Enrolled Practice Location: 552 Highway 54, Santa Rosa, NM 88435 Phone: 505-433-5572 Fax: 877-651-1259 |
Santa Rosa Lion Care Health Center Clinic/Center - Student Health Medicare: Not Enrolled in Medicare Practice Location: 717 S 3rd St, Santa Rosa, NM 88435 Phone: 505-426-2262 Fax: 505-454-1473 |
Sunrise Clinics Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Not Enrolled in Medicare Practice Location: 116 Camino De Vida, Santa Rosa, NM 88435 Phone: 575-472-7747 Fax: 877-651-0289 |
Santa Rosa Medical Clinic Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 533 Lake Dr, Santa Rosa, NM 88435 Phone: 505-472-4311 Fax: 505-472-4313 |
News Archive
In the run-up to this week's giant free clinic in the District, Nicole Lamoureux, the lead organizer, could tell that hearts were racing, blood pressure was increasing and tension was rising. Calls from patients scheduling appointments were starting to pour into her office, but there weren't enough volunteer medical workers to see them.
One of the most common complications during pregnancy is low-back pain, which affects between 50% and 70% of pregnant women. For the population on the whole, lower-back pain is associated to changes in the spine's biomechanics.
The benefits of using insulin to treat diabetes far outweigh the risks, but a review just published online by IJCP, the International Journal of Clinical Practice, suggests that commonly used diabetes therapies may differ from each other when it comes to their influence on cancer risk.
"Lawmakers from both parties are telling the White House they will go on vacation next month and leave behind - and incomplete - President Barack Obama's health care overhaul," the Associated Press reports. The White House had long pushed lawmakers to complete their proposal by the recess, a target that now appears unlikely.
Intellect Neurosciences, Inc., a biopharmaceutical company with internal preclinical and clinical-stage pipelines, as well as multiple licenses with major pharmaceutical companies covering products in late-stage clinical trials, announced that it has received a patent from the United States Patent and Trademark Office (USPTO) related to its internal Alzheimer's disease (AD) monoclonal antibody program.
› Verified 7 days ago